BBNX Beta Bionics, Inc.: institutional ownership and insider trading
144 funds reported holding $826M of Beta Bionics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $20.1M, with 26 new positions and 21 funds selling out; over the last 12 months insiders bought $0 and sold $4.46M on the open market; over its last four quarters it reported revenue of $119M and net income of −$73.0M.
BBNX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $32.0M, net income −$23.4M, EPS -0.53
- Quarter ended Mar 31, 2026: revenue $27.6M, net income −$21.9M, EPS -0.49
- Quarter ended Dec 31, 2025: revenue $32.1M, net income −$13.5M, EPS -0.16
- Quarter ended Sep 30, 2025: revenue $27.3M, net income −$14.2M, EPS -0.33
Famous investors holding BBNX
- Izzy Englander (Millennium Management): $15.0M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $633K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $177K, 0.0% of the portfolio
Largest institutional holders of BBNX
- EVENTIDE ASSET MANAGEMENT, LLC — $98.1M
- Soleus Capital Management, L.P. — $68.8M
- VANGUARD GROUP INC — $67.6M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $66.9M
- Sands Capital Alternatives, LLC — $58.1M
- BlackRock, Inc. (BLK) — $52.3M
- Point72 Asset Management, L.P. — $35.3M
- VANGUARD CAPITAL MANAGEMENT LLC — $27.9M
- Vestal Point Capital, LP — $25.1M
- RTW INVESTMENTS, LP — $23.5M
Recent BBNX insider trades
- Oct 14, 2026: Hopman Mark sold 775 shares ($13.4K)
- Oct 1, 2026: Hopman Mark sold 370 shares ($7.02K)
- Sep 22, 2026: Jones Christy sold 6,430 shares ($148K)
- Sep 16, 2026: Hopman Mark sold 30,779 shares ($620K)
5%+ owners
- T. Rowe Price Associates, Inc.: 16.6% (Schedule 13G, filed Oct 7, 2026)
- Eventide Asset Management, LLC: 13.4% (Schedule 13G/A, filed May 15, 2026)
- Levy Guy: 9.8% (Schedule 13G/A, filed May 8, 2026)
- Dapice Joshua J.: 8.1% (Schedule 13G/A, filed May 12, 2026)
- Divisadero Street Capital Management, LP: 6.9% (Schedule 13G, filed Jul 24, 2026)